CMP: INR587 TP: INR705 (+21%) Upgrade to Buy

Similar documents
Domestic air passengers increase 16.9% in November

CMP: INR64 TP: INR65 (+1%) Neutral Going retail

A win-win combination

CMP: INR270 TP: INR335(+24%) Buy Takes price hike disguised as evacuation charges

CMP: INR80 TP: INR106(+32%) Buy MIB approves merger of VD2H

Sohail Halai Alpesh Mehta

CMP: INR688 TP: INR1,050(+53%) Buy Opportunity in adversity?

Lupin. CMP: INR861 TP: INR1,000(+16%) Buy Goa and Indore plant receives Warning Letter

Domestic shortage driving e-auction prices

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

CMP: INR540 TP: INR650 (+20%) BUY

IDFC Bank. CMP: INR63 TP: INR68 (8%) Neutral

IndusInd Bank. CMP: INR345 TP: INR419 Buy

ECOSCOPE. Real GDP growth eases on lower net indirect taxes. The Economy Observer. Real GVA growth exactly as expected

Idea Cellular. CMP: INR105 TP: INR120 (+15%) Buy Board approves raising INR32.5b via preferential issue

Canara Bank. CMP: INR419 TP: INR525 Buy

Punjab National Bank. CMP: INR716 TP: INR950 Buy

City Union Bank BUY. 24 February 2016 INR82

IDBI Bank. CMP: INR106 TP: INR121 Neutral

CMP: INR759 TP: INR910 (+20%) Upgrade to Buy Ad recovery on the cards

IDFC Bank. CMP: INR61 TP: INR62 (2%) Neutral Focus on inorganic opportunities; stressed assets stable

Focus on premium segment and bridging product gaps

CMP: INR865 TP: INR1,015 (+17%) Buy Building blocks for strong growth

CMP: INR170 TP: INR240 (+41%) Buy Well capitalized for growth

Appoints CapGemini s Salil Parekh as CEO and MD. Potential positives

CMP: INR656 TP: INR780(+19%) Buy Solutions in sight

Banking on innovation to drive growth

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

CMP: INR532 TP: INR675(+27%) Buy

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

M&M Financial Services

Canara Bank. CMP: INR464 TP: INR645 Buy

SKS Microfinance. CMP: INR478 TP: INR589 (+23%) Buy Clouds of uncertainty cleared. RBI to be the sole regulator of the MFI sector

CMP: INR145 TP: INR196 (+33%) Buy Expect orders to spurt in FY19

CMP: INR110 TP: INR130(+17%) Buy Cement division set for a better 2HFY18

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

CMP: INR734 TP: INR764 (+4%) Neutral

Expect capacity-led rerating; maintain Buy

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

CMP: INR678 TP: INR780 (+15%) Buy

Can Fin Homes BUY. 23 September 2015 INR821

CMP: INR228 TP: INR275 (+20%) Buy Firm utilization continues

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Punjab National Bank

CMP: INR400 TP: INR470(+18%) Buy

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Result Update. Nilkamal Limited CMP: INR1675 TP: INR2,184(+30%) Quarterly Standalone Performance (INR mn)

CMP: INR458 TP: INR550 (+20%) Buy

Karnataka Bank. Rating: BUY. Bank - Private. Short Note. Brief Financials

CMP: INR576 TP: INR590 (+2%) Neutral Advancement and PMLA affect 2QFY18 sales

KEY FINANCIAL/VALUATIONS DEEPAK KUMAR BV

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Punjab National Bank. CMP: INR760 TP: INR964 Buy Asset quality deteriorates; asset-liability well-matched Highlights of FY12 Annual Report

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Alpesh Mehta Sohail Halai

CMP: INR272 TP: INR361(+33%) Buy Production ramp-up encouraging

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

CMP: INR475 TP: INR609 (+28%) Buy

Voltas-Beko product line to be launched in 2HCY18. We recently met management of Voltas (VOLT). Key takeaways:

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Idea Cellular. CMP: INR59 TP: INR75(+27%) Buy Near-term headwinds persist

CMP: INR374 TP: INR500 (+34%) Buy Fuelled with capital

Bata India. CMP: INR415 TP: INR483 (+16%) Upgrade to Buy Aggressive, focused strategy to drive growth. Upgrading to Buy

CMP: INR125 TP: INR114 (-9%) Neutral

All round healthy performance

Change EPS. (Rs) FY

BUY. Structural changes in the making CAPITAL FIRST. Target Price: Rs 920. Key drivers

CMP: INR2,623 TP: INR2,875 (+10%) Neutral

CMP: INR2,013 TP: INR2,384 (+18%) DBEL to be merged with OCL India

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

Individual Housing Loans: Rationalization of Risk-Weights and LTV Ratios

Financial summary. Year

CMP: INR840 TP: INR941 (+12%) Neutral TRAI boost to RJio; increasing target price

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Hardick Bora

ECOSCOPE. 3QFY16 CAD/GDP corrects to 1.3% The Economy Observer. Balance of Payments. See surplus in 4Q and to remain low in FY17; INR to correct still

Hold Target Price: Rs 574

CMP: INR949 TP: INR1,140 (+20%) Buy

Indostar Capital Finance

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

CMP: INR830 TP: INR1,040(+25%) Buy Driving value through simplification

No significant jump in retail electronic payments post demonetization

Financial integrity intact; FDA resolution the key

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

Hindustan Zinc. 30 April QFY18 Results Update Sector: Metals. Estimate change TP change Rating change

Muthoot Finance. CMP: INR215 TP: INR266 (+24%) Buy

Repco Home Finance REPCO IN

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

CMP: INR224 TP: INR268 (+20%) Buy

Transcription:

BSE SENSEX S&P CNX 34,346 10,554 Stock Info Bloomberg AUBANK IN Equity Shares (m) 284.3 52-Week Range (INR) 739/358 1, 6, 12 Rel. Per (%) -9/-1/- M.Cap. (INR b) 198.1 M.Cap. (USD b) 3.1 Avg Val, INRm 1285 Free float (%) 67.1 Financials Snapshot (INR b) Y/E MAR FY18E FY19E FY20E NII 11.4 17.0 23.4 PPP 6.1 8.7 12.2 PAT 3.0 4.3 6.1 EPS 10.6 15.3 21.6 BV/Share 80.8 96.4 118.4 P/E (x) 54.9 38.2 27.0 P/BV (x) 7.2 6.0 4.9 RoA (x) 1.8 1.9 2.0 ROE(X) 14.1 17.2 20.1 Shareholding pattern (%) As On Dec-17 Sep-17 Promoter 32.7 32.9 DII 11.6 10.2 FII 7.3 6.4 Others 48.4 50.5 FII Includes depository receipts Stock Performance (since listing) AU Small Finance Sensex - Rebased 700 500 300 100 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 CMP: INR587 TP: INR705 (+21%) Upgrade to Buy Perfect start to a promising journey; Upgrading to Buy 28 February2018 Update Sector: Financials AU Small Finance Bank AU Small Finance Bank (AUBANK) has reported strong progress as it undertakes transitioning from a leading retail-focused NBFC (AU Finance) to a small finance bank (SFB). While migration to an SFB is expected to weigh on the return ratios over the near term, we believe operating costs should peak out in FY18E and will begin to gradually improve thereafter. The bank continues to record robust balance sheet growth and has also surprised positively in terms of liability franchise development (2.7x CD ratio, 37% CASA ratio within three quarters of banking operations), which should provide cushion against a decline in yields. We expect 42% earnings CAGR over FY18-20E, driving RoA/RoE to 1.98%/20.1% in FY20E. Post the recent correction, the stock trades at 4.9x FY20E BV and 27x FY20E EPS. In view of its long-term sustainable business and earnings growth potential, we believe that AUBANK should continue trading at a premium. We thus upgrade the stock to Buy with a target price of INR705 (unchanged), based on 5.9x FY20E BV/32.7x FY20E EPS. Business growth remains robust; diversification set to improve further Post transition to an SFB, AUBANK has launched several new deposit/lending products and also expanded its presence in chosen geographies. Business growth, too, continues to be strong (67% YoY loan growth; 38% YoY AUM growth). Aided by its strong distribution network and launch of new products (including housing finance), AUBANK should deliver 42% loan book CAGR over FY18-20E in our view. We believe loan mix and geographical diversification will add stability to the franchise and help maintain steady growth. Deposit accretion surprises positively; will help cushion against drop in yields arising from banking transition AUBANK has surprised positively in terms of liability franchise development (88% YoY deposits growth in 3Q) and demonstrated robust CASA growth (CASA ratio at 37%, +400bp QoQ). Deposits now form ~37% of total credit v/s 23% in 2QFY18 this should provide protection against a decline in yields, containing contraction in the NIM (~80bp moderation over FY17-20E). Earnings growth to accelerate from FY19E; cost ratios have likely peaked We expect the return ratios to bounce back to healthy levels over FY19-20E as opex ratios have likely peaked out in FY18E while strong build-up of liability franchise will cushion NIM contraction. We believe a diversified loan book, wide geographical presence and strong underwriting skills across different lending segments will enable AUBANK to complete its SFB transition expeditiously. We expect RoA/RoE to bottom out at 1.82%/14.1% in FY18 and recover to 1.98%/20.1% by FY20E. Valuation and view We expect a CAGR of 43% in loan book and 42% in PAT over FY18-20, with RoA/RoE of 1.98%/20.1% in FY20. Post the recent correction, the stock trades at 4.9x FY20E BV, and we believe AUBANK should continue trading at a premium, given its superior performance and accelerated SFB transition. We upgrade to Buy with a TP of INR705 (unchanged), based on two-stage GGM, corresponding to 5.9x FY20E BV. Our PT corresponds to 32.7x FY20E EPS even as we expect the bank to deliver 40%+ earnings CAGR over the medium term. Research Analyst: Nitin Aggarwal (Nitin.Aggarwal@MotilalOswal.com); +91 22 3982 5540 Anirvan Sarkar (Anirvan.Sarkar@MotilalOswal.com); +91 22 3982 5505 Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 3982 5415 Piran Engineer (Piran.Engineer@MotilalOswal.com); +91 22 3980 4393 Investors are advised to refer through important disclosures made at the last page of the Research Report. Motilal Oswal research is available on www.motilaloswal.com/institutional-equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.

Business growth remain robust; off-balance sheet mix to decline further New products to scale up gradually and provide diversification: As an assetfinancing NBFC, AUBANK had built a strong franchise across three secured lending segments: Vehicle loans, MSME loans and SME loans. Post transition to an SFB, it has launched several new deposit/lending products and has also expanded into newer geographies. The bank has also launched the housing finance business where in it has successful prior experience. Given its prior experience in housing finance and rapidly expanding presence in tier-ii/iii centers, AUBANK is well placed to rapidly scale up this business post launch, in our view. Even though the bank s business mix is largely in favor of vehicle and SME loans (82% of AUM), newer products will help it build scale and diversify risks. We expect AUBANK to deliver ~42% loan book CAGR over FY18-20E. Exhibit 1: We expect the bank to register 37% AUM CAGR over FY18-20E AUM (INRb) Loan book (INRb) 148.2 107.3 115.6 82.2 37.0 44.5 55.7 56.2 63.9 18.4 24.6 34.0 201.3 165.1 277.2 235.6 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Source: Company, MOSL Exhibit 2: AUBANK has recorded strong AUM growth across verticals YoY growth in 3QFY18 104.8 Exhibit 3: with increasingly diversified AUM mix Wheels Secured MSME Secured SME Gold loans Agri loans NBFC RE Group Business Banking 25.3 43.8 52.5 5.7 8.4 9.9 30.6 29.7 29.2 Vehicle finance Secured MSME Secured SME NBFC 49.4 47.7 46.7 1QFY18 2QFY18 3QFY18 Decreasing off-bs should improve NIM (including off-bs): As a bank, AUBANK has access to deposits we note that it has progressed well on deposits accretion, bringing down incremental cost of funds. This will enable AUBANK to engage in more direct lending rather than securitization / direct assignment of loans which it had resorted to in a higher cost of funds scenario as an NBFC. We expect off-bs loan contribution to decline to 15% of total AUM by FY20E from ~25% now. 28 February 2018 2

Exhibit 4: Off-BS loans as % of total AUM should decline to 15% by FY20E Off BS % Exhibit 5: NIM (including off BS) to remain stable over FY18-20E NIM (including off BS) 50.2 44.8 38.9 31.6 40.5 22.0 18.0 15.0 6.0 6.1 8.2 8.7 8.2 8.3 8.6 8.4 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Fee income growth to be supported by distribution fees Third-party distribution fee growth should offset likely moderation in PSLC fees: As an SFB, AUBANK is required to maintain 75% of PSL-compliant loans on its books. As the bank diversifies its product mix in favor of non-psl compliant loans, it will decrease the quantum of PSL certificates the bank can sell, leading to some moderation in PSLC fees. However, this will likely get compensated by healthy growth in third-party distribution fees, as the bank has tied up with 11 mutual funds, one health insurance and one non-life insurance company to distribute their products. Deposit build-up beats expectations; to form 68% of total funds by FY20E Fast-paced deposit accretion to cushion against drop in yields: AUBANK has surprised positively with fast-paced build-up of its liability franchise (88% YoY deposits growth in 3Q) while also demonstrating robust CASA growth (CASA ratio at 37%, +400bp QoQ). The CD ratio has improved to 270% in 3QFY18 within just nine months of the launch of its banking operations. Accelerated deposits build-up has favored cost of funds, as incremental cost of funds for 9MFY18 stands at 7.2%, with cost of deposits at 6.55%. Granularity of deposits is at a healthy level, with an average SA ticket size of INR40,000. We note that 89% of AUBANK s deposits come from new to bank customers. We believe that robust growth in deposits will protect against a decline in yields, containing NIM contraction (9.3% in FY20 v/s 10.1% in FY17, excluding off-bs). 28 February 2018 3

Exhibit 6: Funding mix incrementally diversified with growing mix of deposits (34% in 3QFY18) NCDs Refinance CPs Loans-Banks and NBFC Deposits Others Exhibit 7: We expect deposits to form 68% of total funds by FY20E Deposits Borrowings 0 0 23 18 10 21 13 7 14 11 8 21 6 12 16 21 34 05 23 58.6 40.8 31.8 45 50 46 40 34 2QFY17 4QFY17 1QFY18 2QFY18 3QFY18 41.4 59.2 68.2 FY18E FY19E FY20E Exhibit 8: CASA ratio is best-in-class among listed SFBs, even though AUBANK started operations after Equitas and Ujjivan Exhibit 9: Cost of funds to decline steadily aided by healthy deposit accretion CASA ratio Cost of funds 12.3 12.5 11.3 10.3 8.4 7.5 7.1 6.9 37.2 32.6 3.7 AU Bank Equitas Ujjivan Source: Company, MOSL FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Source: Company, MOSL Asset quality improving post a minor bump-up from GST/90dpd migration Asset quality to improve with stabilization in vehicle portfolio: A large proportion of secured advances, strong underwriting and effective credit monitoring has enabled AUBANK to maintain NPL ratios at controlled levels. However, post the launch of its SFB operations, migration to the 90dpd recognition basis in 1QFY18, combined with inability to recognize repossessed vehicles as a bank (NBFCs are allowed) had resulted in an increase in the GNPL ratio to ~3%. Vehicle finance portfolio NPAs are partly also due to GST implementation which had impacted AUBANK s customer segment. However, as the implementation issues iron out, asset quality in this segment should improve further. In 3QFY18, asset quality improved slightly with ~19% QoQ decline in fresh slippages to INR680m, leading to a 25/22bp QoQ improvement in the GNPA/NNPA ratios to 2.83%/1.87% (2.12%/1.40% including off-balance sheet). Vehicle finance GNPAs declined to 3.2% in 3QFY18 from 3.7% in 2QFY18. PCR for the bank had declined post 4QFY17 due to aggressive write-offs (the bank provides 100% for loans that are delinquent for > 730 days), but improved to 34.4% in 3QFY18 from 28.6% in 1QFY18. Management has guided for a further improvement in PCR to 38-40% by end-fy18. 28 February 2018 4

Exhibit 10: Asset quality expected to improve steadily GNPA NNPA PCR 50.0 50.0 50.0 1.3 0.5 0.6 0.4 0.2 0.3 52.5 40.2 35.3 35.9 1.0 1.1 1.7 0.7 1.7 0.5 0.4 2.7 45.4 2.6 1.4 50.7 1.2 2.4 FY12 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Earnings growth to accelerate from FY19E; cost-ratios have likely peaked Transitioning into an SFB will impact the return ratios on (i) negative carry due to CRR/SLR, resulting in margin compression and (ii) higher operating expenses due to investments in technology, branches, operating centers, employees, etc. However, we believe that operating expenses will peak out in FY18E and operating leverage should improve gradually FY19E onward. We also believe that fast-paced deposit accretion will help reduce incremental cost of funds, helping cushion against NIM contraction. We expect the return ratios to bounce back to healthy levels over FY19-20E. Exhibit 11: Operating leverage is expected to improve FY19 onward Cost to income 54.0 45.2 40.2 36.6 2.8 2.4 2.5 2.3 Cost to average assets 54.4 54.3 53.2 40.9 39.3 4.4 4.6 4.5 3.4 3.0 FY12 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E We believe a diverse loan book, wide geographical presence and strong underwriting skills across different lending segments will enable AUBANK to complete its SFB transition expeditiously. We expect RoA/RoE to bottom out at 1.82%/14.1% in FY18 and recover to 1.98%/20.1% by FY20E. 28 February 2018 5

Exhibit 12:...leading to an improvement in RoA/RoE over FY19/20E RoA RoE 17.8 13.6 19.9 2.5 23.3 2.8 20.4 2.6 14.1 17.2 20.1 1.7 1.4 1.8 1.9 2.0 FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY20E Valuation view We expect a CAGR of 43% in loan book and 42% in PAT over FY18-20, with RoA/RoE of 1.98%/20.1% in FY20. Considering the likelihood of business and earnings growth sustainability with strong management at the helm, we believe the stock should continue trading at a premium. Post the recent correction, the stock trades at 4.9x FY20E BV. We thus upgrade AUBANK to Buy, with a target price of INR705 (unchanged), based on two-stage GGM, corresponding to 5.9x FY20E BV. 28 February 2018 6

Financials and Valuations INCOME STATEMENT (INR Million) Y/E MARCH 2013 2014 2015 2016 2017 2018E 2019E 2020E Interest Income 3,370 4,984 6,429 9,351 12,298 18,761 27,995 38,873 Interest Expense 1,972 2,876 2,820 3,953 5,003 7,402 10,964 15,487 Net Financing income 1,398 2,108 3,609 5,399 7,294 11,359 17,031 23,386 Change (%) 169.6 50.8 71.2 49.6 35.1 55.7 49.9 37.3 Income from Sec. 711 656 610 753 1,441 1,521 1,273 1,284 Net Income (Incl Secur) 2,109 2,764 4,219 6,152 8,736 12,880 18,305 24,669 Change (%) 73.4 31.1 52.7 45.8 42.0 47.4 42.1 34.8 Other Income 24 58 24 50 135 473 829 1,326 Net Income 2,133 2,822 4,243 6,202 8,871 13,353 19,133 25,995 Change (%) 74.2 32.3 50.4 46.2 43.0 50.5 43.3 35.9 Operating Expenses 965 1,134 1,554 2,538 3,489 7,270 10,387 13,818 Change (%) 45.9 17.6 37.0 63.3 37.5 108.3 42.9 33.0 Operating Profits 1,168 1,688 2,690 3,665 5,382 6,084 8,746 12,177 Change (%) 107.6 44.4 59.4 36.2 46.9 13.0 43.8 39.2 Total Provisions 168 607 606 438 652 1,508 2,162 2,886 % to operating income 14.4 36.0 22.5 12.0 12.1 24.8 24.7 23.7 PBT 1,001 1,081 2,084 3,226 4,730 4,576 6,584 9,291 Exceptional items 0 0 0 0 6,703 0 0 0 PBT including exceptional 1,001 1,081 2,084 3,226 11,433 4,576 6,584 9,291 Tax 333 371 681 1,110 3,214 1,556 2,239 3,159 Tax Rate (%) 33.3 34.3 32.7 34.4 28.1 34.0 34.0 34.0 PAT 668 709 1,402 2,116 8,220 3,020 4,345 6,132 Adjusted PAT 668 709 1,402 2,116 3,400 3,020 4,345 6,132 Change (%) 106.4 6.3 97.7 50.9 288.4-63.3 43.9 41.1 Change (on adjusted basis) (%) 106.4 6.3 97.7 50.9 60.7-11.2 43.9 41.1 BALANCE SHEET Y/E MARCH 2013 2014 2015 2016 2017 2018E 2019E 2020E Equity Share Capital 405 430 441 441 2,843 2,843 2,843 2,843 Reserves & Surplus 4,014 5,548 7,667 9,654 17,033 20,130 24,572 30,824 Equity Networth 4,419 5,978 8,108 10,094 19,876 22,973 27,414 33,666 Interest bearing liabilities 24,821 21,300 28,783 47,826 70,710 1,26,745 1,81,947 2,68,433 Change (%) Other liabilities 1,889 2,308 3,462 5,022 7,531 8,661 12,991 17,538 Change (%) 22.2 50.0 45.0 50.0 15.0 50.0 35.0 Total Liabilities 31,128 29,586 40,353 62,942 98,117 1,58,440 2,22,414 3,19,699 Loans 18,432 24,560 34,040 56,208 63,900 1,15,587 1,65,051 2,35,594 Change (%) 33.3 38.6 65.1 13.7 80.9 42.8 42.7 Investments 7,387 1,136 1,398 2,316 21,503 30,104 41,544 60,239 Net Fixed Assets 168 169 194 246 2,758 6,896 13,103 22,930 Other assets 5,142 3,721 4,721 4,172 9,956 4,353 842-1,500 Total Assets 31,128 29,586 40,353 62,942 98,117 1,58,440 2,22,414 3,19,699 Total Assets (incl. off BS) 49,740 49,516 61,990 88,947 1,41,556 1,91,042 2,58,645 3,61,275 AUM Mix 2013 2014 2015 2016 2017 2018E 2019E 2020E AUM (INR b) 37,043 44,490 55,677 82,213 1,07,339 1,48,189 2,01,282 2,77,169 Change (%) 45.0 20.1 25.1 47.7 30.6 38.1 35.8 37.7 On BS (%) 49.8 55.2 61.1 68.4 59.5 78.0 82.0 85.0 Off BS (%) 50.2 44.8 38.9 31.6 40.5 22.0 18.0 15.0 28 February 2018 7

Financials and Valuations RATIOS Y/E MARCH 2013 2014 2015 2016 2017 2018E 2019E 2020E Spreads Analysis (%) Avg. Yield - on earning assets 19.1 19.3 21.0 19.9 17.1 16.1 15.7 15.3 Avg. Yield - on loans 22.8 22.1 21.4 20.5 20.3 18.9 18.2 17.7 Avg. Cost of funds 12.3 12.5 11.3 10.3 8.4 7.5 7.1 6.9 Spreads 10.5 9.6 10.1 10.2 11.9 11.4 11.1 10.8 Net Interest Margin 7.9 8.2 11.8 11.5 10.1 9.8 9.7 9.3 Net Interest Margin (Incl off BS) 6.0 6.1 8.2 8.7 8.2 8.3 8.6 8.4 Profitability Ratios (%) RoE 17.8 13.6 19.9 23.3 20.4 14.1 17.2 20.1 RoA (On balance Sheet) 3.1 2.3 4.0 4.1 3.8 2.4 2.3 2.3 RoA (incl off BS AUM) 1.7 1.4 2.5 2.8 2.6 1.82 1.93 1.98 Op. Exps./Net Income 45.2 40.2 36.6 40.9 39.3 54.4 54.3 53.2 Empl. Cost/Op. Exps. 54.6 61.4 60.8 62.2 55.2 59.7 60.5 61.4 Asset-Liability Profile (%) Net NPAs to Adv. 0.3 0.6 0.5 0.4 1.1 1.7 1.4 1.2 Debt/Equity (x) 5.6 3.6 3.6 4.7 3.6 5.5 6.6 8.0 Assets/Equity (Avg) 5.7 5.8 5.0 5.7 5.4 6.0 7.6 8.9 Assets/Equity (Avg - Incl off) 10.4 9.5 7.9 8.3 7.7 7.8 8.9 10.1 CAR 18.3 18.8 17.3 16.9 23.2 19.5 17.0 16.2 Tier I 14.9 15.7 15.8 13.5 21.1 17.4 15.4 13.6 Valuations 2013 2014 2015 2016 2017 2018E 2019E 2020E Book Value (INR) 109.2 139.1 183.9 228.9 69.9 80.8 96.4 118.4 BV Growth (%) 27.4 32.2 24.5-69.5 15.6 19.3 22.8 Price-BV (x) 7.2 6.0 4.9 EPS (INR) 17.0 32.2 48.0 18.6 10.6 15.3 21.6 Adjusted EPS (INR) 17.0 32.2 48.0 20.7 10.6 15.3 21.6 EPS Growth (%) 89.4 49.0-61.3-42.8 43.9 41.1 Price-Earnings (x) 54.9 38.2 27.0 E: MOSL Estimates 28 February 2018 8

N O T E S 28 February 2018 9

Explanation of Investment Rating Investment Rating Expected return (over 12-month) BUY >=15% SELL < - 10% NEUTRAL > - 10 % to 15% UNDER REVIEW Rating may undergo a change NOT RATED We have forward looking estimates for the stock but we refrain from assigning recommendation *In case the recommendation given by the Research Analyst becomes inconsistent with the investment rating legend, the Research Analyst shall within 28 days of the inconsistency, take appropriate measures to make the recommendation consistent with the investment rating legend. Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations). AU Small Finance Bank Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company, the details in respect of which are available on www.motilaloswal.com. MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited (BSE), Metropolitan Stock Exchange Of India Ltd. (MSE) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository Limited (NSDL) and is member of Association of Mutual Funds of India (AMFI) for distribution of financial products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at http://onlinereports.motilaloswal.com/dormant/documents/associate%20details.pdf Regulatory Enquiries against Motilal Oswal Securities Limited by SEBI: SEBI pursuant to a complaint from client Shri C.R. Mohanraj alleging unauthorized trading, issued a letter dated 29th April 2014 to MOSL notifying appointment of an Adjudicating Officer as per SEBI regulations to hold inquiry and adjudge violation of SEBI Regulations; MOSL requested SEBI to provide all documents, records, investigation report relied upon by SEBI which were referred in Show Cause Notice. The matter is closed and MOSL had to pay Rs. 2 lakhs towards penalty for misplacement of original POA of client. MOSL, it s associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company at the end of the month immediately preceding the date of publication of the Research Report. MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report. Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have received any compensation from the subject company in the past 12 months. In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have: a) managed or co-managed public offering of securities from subject company of this research report, b) received compensation for investment banking or merchant banking or brokerage services from subject company of this research report, c) received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report. d) Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report. MOSL and it s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Terms & Conditions: This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by virtue of their receiving this report. Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. Disclosure of Interest Statement AU Small Finance Bank Analyst ownership of the stock No A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL or its associates maintains arm s length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have expressed their views. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL & its group companies to registration or licensing requirements within such jurisdictions. For Hong Kong: This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) SFO. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to Professional Investors as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only available to professional investor and will be engaged only with professional investors. Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Disclaimer: The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval. MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. The person accessing this information specifically agrees to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id: na@motilaloswal.com, Contact No.:022-30801085. Registration details of group entities.: MOSL: SEBI Registration: INZ000158836 (BSE/NSE/MSE); CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser: INA000007100. Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) offers wealth management solutions. *Motilal Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers Commodities Products. * Motilal Oswal Real Estate Investment Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products 28 February 2018 10